Skip to main content
OpenTrials
Completed

NCT Number: NCT03251235

Neural Effects of Cognitive-behaviour Therapy in Panic Disorder

Exposure-based cognitive-behaviour therapy (CBT) for anxiety disorders is an effective intervention, but the brain mechanisms driving recovery are largely unknown. In this experimental medicine study, it will be investigated to what degree CBT affects neural markers of anxiety at an early stage of treatment, to identify dynamic mechanistic changes which might be crucial in the process of recovery as opposed to those seen following full treatment completion. Patients with panic disorder will be recruited and randomly allocated to a group receiving 4 weekly sessions of cognitive-behaviour therapy versus a waiting group not receiving any interventions until after the experimental procedure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

PURPOSE The primary purpose is to enhance our understanding of the mechanisms essential in effective treatment of panic disorder.

METHODS Design: The present study has a between-subjects design, including a waiting group of participants with panic symptoms and a treatment group of participants with panic symptoms who will receive cognitive-behavioural treatment before being tested.

Participants: Twenty-eight volunteers with panic symptoms will be recruited. For participants who do meet the basic study criteria a phone screening appointment (10 - 30 mins) will be arranged to further screen for relevant inclusion and exclusion criteria. They will then be invited to the Department of Psychiatry for the pre-assessment session.

Treatment: Within the study, the investigators will offer participants a brief CBT course of 4 sessions, offered by the Lupina service. The Lupina Service forms part of the OBMH primary care Counselling & Psychology Service, based at the Warneford Hospital. It provides intensive individual CBT for panic disorder and agoraphobia and is staffed by trained graduate volunteer therapists. Potential therapists are psychology graduates with prior mental health experience, who are given 2 days' intensive training in CBT for panic disorder and agoraphobia by Alison Croft, Consultant Clinical Psychologist. They then receive group supervision of their clinical cases. Service evaluation indicates equivalent clinical outcomes for volunteer therapists relative to qualified clinical psychologists.

Procedure: Participants will be randomly allocated to either the treatment group or the waiting group. On arrival to the pre-assessment session, participants will be given a copy of the information sheet (previously seen during the online screening and e-mailed/ posted to them). They will be invited to fill out the consent form. Screening for past or previous psychiatric illness will be achieved using a structured clinical interview (SCID). In addition, participants will be asked to complete a battery of questionnaires. They will also be familiarised with the procedure occurring on the scanning day. Any outstanding questions the participant has will be addressed. The visit lasts about 1 to 1 ½ hrs. After the pre-assessment, a 4 weeks follow-up appointment (post-assessment) will be arranged with all participants. Half of the participants will be referred for treatment in the LUPINA group during that time. At the post-assessment 4 weeks later, the participants will be asked to come to the OCMR (Oxford Clinical Resonance Imaging) Department at the John Radcliffe Hospital. The visit will last a total of 2½ to 3 hrs and include a scanning session lasting 1 to 1 ½ hrs. Subjective mood will be assessed on the day of the scan using the State form of the State-Trait Anxiety Inventory, a Mood Visual Analogue Scale and the Positive and Negative Affect Schedule. In addition, subjects will again complete the questionnaires from the pre-assessment. After the scan, participants will work on two behavioural computer tasks using emotional faces and word stimuli to assess facial recognition and attention outside the scanner. At the end of the session, patients from the waiting group will be offered the taster-CBT treatment within the LUPINA service.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18-70
  • Sufficiently fluent in English to understand the task and instructions
  • PDSS score of at least 6
  • At least two full panic attacks or limited symptoms attacks last 4 weeks

Exclusion criteria

  • CNS-acting medication (antidepressants within last 6 months, benzodiazepine last 3 days)
  • Current or past history of alcohol/ drug abuse
  • Serious medical conditions (e.g., epilepsy, heart or respiratory problems)
  • Done the task before
  • Waiting group: under current psychotherapeutic treatment
  • Pregnancy
  • Contraindications to MRI e.g. pacemaker, mechanical heart valve, hip replacement, metal implants
  • Severe claustrophobia that limits ability to participate in fMRI scanning

Treatment and study plan

Cognitive Behaviour Therapy

Behavioral

Other names: CBT

Primary outcomes

  1. Emotional processing

    Time frame: Treatment Group: post 4-week CBT treatment, waiting Group: post 4-week waiting

    Activation levels in the fear circuit of the brain in response to emotional stimuli (fMRI)

Secondary outcomes

  1. Clinical symptom severity - Global anxiety and depression (self-report)

    Time frame: Baseline, after 4 weeks treatment/ waiting

    Hamilton Anxiety and Depression Scale HADS

  2. Clinical symptom severity - Fear of physical sensations (self-report)

    Time frame: Baseline, after 4 weeks treatment/ waiting

    Body Sensations Questionnaire BSQ

  3. Clinical symptom severity - Agoraphobic fear (self-report)

    Time frame: Baseline, after 4 weeks treatment/ waiting

    Agoraphobic Cognitions Questionnaire ACQ

  4. Clinical symptom severity - Clinical severity and improvement (clinician-report)

    Time frame: Baseline, after 4 weeks treatment/ waiting

    Clinical Global Impression Scale CGI

Sponsors and collaborators

Lead sponsor

University of Oxford

Other

Registry information

Important dates

Study start
2011
Primary completion
2013
Study completion
2016
First posted
Aug 16, 2017
Registry last updated
Aug 16, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.